Previous close | 1.3000 |
Open | 0.7000 |
Bid | 0.4000 |
Ask | 0.5500 |
Strike | 50.00 |
Expiry date | 2025-01-17 |
Day's range | 0.3500 - 0.7000 |
Contract range | N/A |
Volume | |
Open interest | 2.04k |
Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Baxter (BAX) reports better-than-expected first-quarter earnings and sales. BAX's quarterly results reflect solid demand for a range of its medically essential products.
Robust Operational Performance Drives Growth Amidst Strategic Transformations